Searchable abstracts of presentations at key conferences in endocrinology

ea0019p353 | Thyroid | SFEBES2009

Thyroid dysfunction in a Hepatitis C population treated with interferon therapy

Costelloe S , Wassef N , Morris C , Schulz J , Vaghjani T , Thomas M , Jacobs M , Dusheiko G , Vanderpump M

Interferon alpha (IFNα) and Ribavirin combination therapy effectively eradicates Hepatitis C Virus (HCV) in up to 80% of patients. Transient thyroid dysfunction (TD) (>80% hypothyroidism) usually due to a destructive thyroiditis has been recognised to occur in up to 25% of patients treated in Italy, Japan and Australia. However, data are lacking in a UK cohort and no standardised protocol for testing of thyroid function testing exists. The aim of this study was to det...